Covidien : Definitive Agreement to Sell Sleep Therapy Product Line

Jun 01, 2010 - Covidien Announces Portfolio Management Activities - Definitive Agreement to Sell Sleep Therapy Product Line - Completion of Sale of U.S. Radiopharmacies - Covidien (NYSE: COV), a leading global provider of healthcare products, announced a definitive agreement to sell its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a privately held company located in Luxembourg.

PH Invest will acquire the CPAP and Bi-level products, including the Nancy, France manufacturing facility, as well as related commercial operations in Europe. Several products, which are sold under the GoodKnight(TM) and Sandman(TM) brands, are included in this agreement. The agreement excludes the sleep interface products sold and marketed under the brand names Adam(TM), Breeze(TM) and Dreamfit(TM), which will continue to be sold by Covidien. Financial terms of this transaction were not disclosed... Covidien's Press Release -

Covidien : Sale of Sleep Diagnostics Product Line

Sep. 21, 2009-- Covidien, a leading global provider of healthcare products, announced that it had completed the previously announced sale of its Sleep Diagnostics assets to Embla Systems. Financial terms of the transaction were not disclosed.

The sale of the Sleep Diagnostics product line, which includes several products sold under the Sandman™ brand, was made following a thorough review and evaluation of a number of strategic alternatives. The decision is consistent with Covidien’s strategy to streamline its portfolio and reallocate resources to its faster-growing, higher-margin businesses, where the Company has or can develop a global competitive advantage... Covidien's Press Release -

Covidien : Latest Advance In "Unite to Treat Sleep Apnea" Initiative

10/21/08 - Covidien (NYSE: COV, BSX: COV), a leading global healthcare products company, announced the launch of Sandman Alliance(SM), a first-of-its-kind sleep therapy management program. The Sandman Alliance program is the latest addition to Covidien's "Unite to Treat Sleep Apnea" initiative to improve the diagnosis and treatment of sleep disorders.

The Sandman Alliance program unites patients, sleep clinicians and home care providers in their efforts to treat obstructive sleep apnea (OSA) and other sleep disorders. The patient compliance program provides education, support and encouragement to OSA patients to enhance treatment compliance through personal coaching and empowerment. The program links a sleep counselor with each patient to document progress and track the patient's therapy using a web interface, which provides a common area for the patient's sleep physician to log in and monitor the patient's performance under the program. To support this offering and facilitate its delivery, Covidien has partnered with Assist Management, Inc.

Globally, less than 50 percent of OSA patients recommended for continuous positive airway pressure treatment continue their therapy beyond the first week, and up to 25 percent of remaining patients can be expected to discontinue CPAP use within three years... Covidien's Press Release -

Covidien Partners with Sleep Pointe to Bring Sleep Apnea Education, Diagnosis and Treatment to Transportation Industry

Jun 19, 2008 - Covidien (NYSE: COV, BSX: COV), a leading global healthcare products company, announced the latest advance in its "Unite to Treat Sleep Apnea" initiative, an integrated program connecting physicians, sleep labs, treatment providers and patients to improve the diagnosis and treatment of those afflicted with obstructive sleep apnea. The Company is now partnering with Sleep Pointe, an organization dedicated to providing sleep apnea management and wellness programs within the transportation industry.


Covidien created the "Unite to Treat Sleep Apnea" initiative in response to the increased demand for sleep apnea treatment. According to the National Institutes of Health, approximately 12 million Americans suffer from sleep apnea, and an additional 10 million remain undiagnosed... Sleep Pointe's Press Release -

Covidien, Sandman Intro CPAP Device

Feb 11, 2008 - Covidien Ltd. (NYSE: COV, BSX: COV), a leading supplier of continuous positive airway pressure (CPAP) and other sleep therapy devices and accessories, announced the introduction of an all-new CPAP device with a fully-integrated heated humidifier. The product is available throughout the United States and Europe and will be phased into other global markets over the next year.

The Sandman Intro(TM) CPAP device is a convenient device designed for a broad range of patients and provides continuous positive airway pressure and heated humidification. According to Andy Ray, Vice President and General Manager for Covidien's Sleep and Oxygen Division, "The goal in developing this product was to improve the nighttime breathing comfort of patients with obstructive sleep apnea (OSA) - which we know to be an increasingly common and serious condition - and to accomplish this with a device that is as easy to use as it is unobtrusive."... Covidien's Press Release-